Get the Stockscreener App
26.91
1.09%
0.29
After Hours:
26.88
-0.03
-0.11%
Overview
News
Price History
Option Chain
Financials
Why PFE Down?
Discussions
Forecast
Stock Split
Dividend History
Pfizer Inc stock is traded at $26.91, with a volume of 31.58M.
It is up +1.09% in the last 24 hours and up +1.85% over the past month.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
See More
Previous Close:
$26.62
Open:
$26.66
24h Volume:
31.58M
Relative Volume:
0.77
Market Cap:
$152.36B
Revenue:
$59.37B
Net Income/Loss:
$4.25B
P/E Ratio:
36.36
EPS:
0.74
Net Cash Flow:
$8.23B
1W Performance:
+1.78%
1M Performance:
+1.85%
6M Performance:
-14.27%
1Y Performance:
-0.41%
1-Day Range:
$26.58
$27.01
1-Week Range:
$25.96
$27.07
52-Week Range:
$24.48
$31.54
Pfizer Inc Stock (PFE) Company Profile
Name
Pfizer Inc
Sector
Industry
Phone
(212) 733-2323
Address
66 HUDSON BOULEVARD EAST, NEW YORK, NY
Compare PFE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
26.91 | 152.36B | 59.37B | 4.25B | 8.23B | 0.74 |
|
LLY
Lilly Eli Co
|
823.23 | 778.66B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
85.34 | 379.90B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
152.87 | 344.63B | 88.82B | 14.07B | 19.03B | 5.79 |
|
ABBV
Abbvie Inc
|
175.59 | 310.55B | 55.53B | 5.12B | 15.62B | 2.88 |
|
MRK
Merck Co Inc
|
98.92 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
Pfizer Inc Stock (PFE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-24 | Resumed | BofA Securities | Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Underperform |
| Oct-25-24 | Resumed | Citigroup | Neutral |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Aug-07-24 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Mar-22-24 | Downgrade | Argus | Buy → Hold |
| Feb-23-24 | Initiated | Guggenheim | Buy |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Oct-20-23 | Resumed | UBS | Neutral |
| Oct-16-23 | Upgrade | Jefferies | Hold → Buy |
| Jul-17-23 | Reiterated | JP Morgan | Neutral |
| Jul-14-23 | Initiated | HSBC Securities | Buy |
| Jun-29-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-11-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Mar-06-23 | Initiated | Jefferies | Hold |
| Feb-07-23 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jan-26-23 | Downgrade | UBS | Buy → Neutral |
| Jan-17-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-04-23 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Nov-18-22 | Initiated | Credit Suisse | Outperform |
| May-23-22 | Initiated | SVB Leerink | Mkt Perform |
| Apr-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-05-22 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-03-22 | Reiterated | Bernstein | Mkt Perform |
| Dec-20-21 | Reiterated | Cowen | Outperform |
| Dec-17-21 | Initiated | Goldman | Neutral |
| Dec-13-21 | Upgrade | UBS | Neutral → Buy |
| Dec-09-21 | Initiated | Wells Fargo | Overweight |
| Nov-19-21 | Initiated | BMO Capital Markets | Outperform |
| Jul-27-21 | Resumed | Truist | Buy |
| May-06-21 | Downgrade | Mizuho | Buy → Neutral |
| Apr-07-21 | Resumed | RBC Capital Mkts | Sector Perform |
| Feb-04-21 | Upgrade | DZ Bank | Hold → Buy |
| Dec-16-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-19-20 | Resumed | Goldman | Neutral |
| Nov-10-20 | Resumed | Bernstein | Mkt Perform |
| Oct-12-20 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Sep-29-20 | Initiated | Berenberg | Hold |
| Jun-16-20 | Initiated | SVB Leerink | Mkt Perform |
| Feb-27-20 | Initiated | Barclays | Equal Weight |
| Feb-27-20 | Upgrade | Standpoint Research | Hold → Buy |
| Feb-06-20 | Initiated | Mizuho | Buy |
| Jan-07-20 | Initiated | RBC Capital Mkts | Outperform |
| Oct-17-19 | Resumed | BofA/Merrill | Neutral |
| Jul-30-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jul-30-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-04-19 | Resumed | Morgan Stanley | Overweight |
| Feb-20-19 | Resumed | Citigroup | Neutral |
| Jan-31-19 | Upgrade | Argus | Hold → Buy |
| Jan-31-19 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jan-23-19 | Downgrade | UBS | Buy → Neutral |
| Dec-11-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-01-18 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
View All
Pfizer Inc Stock (PFE) Latest News
Jim Cramer on Pfizer Inc. (PFE): ‘It’s Too Low To Sell’ - Insider Monkey
Pfizer Stock Outlook: Is Wall Street Bullish or Bearish? - Nasdaq
Peering Into Pfizer's Recent Short Interest - Benzinga
Pfizer Recognized as “2024 Corporate Partner of the Year” by American Cancer Society - Pfizer
Pfizer (PFE) is a Top-Ranked Momentum Stock: Should You Buy? - Yahoo Finance
Lewis Asset Management LLC Sells 22,613 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Acquired by Capital Investment Advisory Services LLC - MarketBeat
OLD National Bancorp IN Decreases Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Murphy Pohlad Asset Management LLC - MarketBeat
Drystone LLC Takes $3.87 Million Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Foster & Motley Inc. Has $3.26 Million Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Asset Dedication LLC Boosts Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Protein Therapeutics Market is estimated to reach $566.66 Billion by 2030 | Pfizer Inc., Johnson and Johnson, - EIN News
Pfizer's SWOT analysis: pharmaceutical giant faces post-covid challenges - MSN
Pfizer director Daniel Cronin sells shares worth $20,140 - Investing.com
Petra closes fifth fund at $270m, Northwind funds Pfizer HQ conversion loan - Alternatives Watch
NYC Project to Convert Former Pfizer Headquarters Lands $135 Million Loan - MSN
Pfizer (NYSE:PFE) Trading 0.4% HigherHere's Why - MarketBeat
BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
Project to convert former Pfizer HQ into housing lands $135M loan - Crain's New York Business
Swedbank AB Sells 614,657 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer to pay nearly $60M over kickbacks for migraine drug developed by New Haven-based Biohaven - Hartford Business Journal
Allen Capital Group LLC Has $3.33 Million Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Purchased by Hantz Financial Services Inc. - MarketBeat
Forsta AP Fonden Reduces Stock Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Acquired by Robeco Institutional Asset Management B.V. - MarketBeat
Pfizer’s Stock Plunge: A Hidden Treasure for Savvy Investors? - Jomfruland.net
Pfizer: to present its advances in oncology -January 29, 2025 at 07:20 am EST - Marketscreener.com
Barry Investment Advisors LLC Has $4.64 Million Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Perigon Wealth Management LLC Sells 14,869 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer (NYSE:PFE) Stock Price Down 0.6% on Analyst Downgrade - MarketBeat
Pregabalin Market Detailed In New Research Report 2025 | Pfizer, Novartis AG, Sanofi - openPR
Is Pfizer the Safe Stock You Should Consider Investing in for 2025? - Jomfruland.net
Is Pfizer Inc. (PFE) the Safe Stock to Buy for the Long Term in 2025? - Insider Monkey
Pfizer (PFE) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Nebraska joins in settling kickback allegations against Biohaven Pharmaceutical Holding Company Ltd. - News Channel Nebraska
Nebraska joins multi-state settlement against Biohaven Pharmaceutical for kickback allegations - newschannelnebraska.com
Pfizer Q4 Earnings Preview: 5 Critical Business Issues To Consider (NYSE:PFE) - Seeking Alpha
Pfizer Inc. (PFE): Is This Healthcare Stock A Good Buy? - Yahoo Finance
Pfizer Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) - Benzinga
Pfizer's Options: A Look at What the Big Money is Thinking - Benzinga
Pfizer (NYSE:PFE) Stock Price Down 0.6% After Analyst Downgrade - MarketBeat
Here's How to Play Pfizer Stock Before Q4 Earnings Release - Yahoo Finance
Matrix Asset Advisors Inc. NY Sells 38,127 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Patrick M Sweeney & Associates Inc. Has $2.08 Million Stake in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Next Level Private LLC - MarketBeat
Griffin Asset Management Inc. Has $2.18 Million Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Warner Financial Inc. - MarketBeat
Buffington Mohr McNeal Makes New Investment in Pfizer Inc. (NYSE:PFE) - MarketBeat
BankPlus Wealth Management LLC Buys New Shares in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium - The Bakersfield Californian
Pfizer Inc Stock (PFE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):